Clinical trial
Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression
NCT00157547 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00157547 |
|---|---|
| Title | Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression |
| Official title | The Use of Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Major Depressive Disorder |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Medtronic - MITG Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | Selective serotonin reuptake inhibitors (SSRI) |
| Enrollment | 95 |
| Start date | Apr 1, 2003 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | May 28, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: